
Sign up to save your podcasts
Or


The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
By JAMA Network4.3
106106 ratings
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines

497 Listeners

162 Listeners

8,858 Listeners

112,236 Listeners

38 Listeners

21 Listeners

13 Listeners

11 Listeners

9 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

29 Listeners

9 Listeners

92 Listeners

14 Listeners

5 Listeners

5 Listeners

370 Listeners

5,804 Listeners

18 Listeners

3 Listeners